USA flag logo/image

An Official Website of the United States Government

Single-Base Resolution Method of 5-hmC in Biology

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R43HG006634
Solicitation Year:
2012
Solicitation Topic Code:
NHGRI
Solicitation Number:
PA11-096
Small Business Information
CINLANIAN BIOTECHNOLOGY, INC.
4095 CLAIRMONT ROAD ATLANTA, GA 30341-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: Single-Base Resolution Method of 5-hmC in Biology
Agency: HHS
Contract: 1R43HG006634-01
Award Amount: $212,188.00
 

Abstract:

DESCRIPTION (provided by applicant): 5-Hydroxymethylcytosine (5-hmC) is a newly identified base modification in mammalian genomic DNA. Because current sequencing methods cannot differentiate 5-meC from 5-hmC, the immediate challenge is to develop robust methods to ascertain the positions of 5-hmC within the mammalian genome, a problem best addressed by adapting a new chemical labeling technology that we have developed. We show that the hydroxymethyl group of 5-hmC can be selectively labeled with chemicallymodified glucoses using 2-glucosyltransferase (2GT). This glycosylation offers a strategy of installing functional groups such as biotin onto 5-hmC. In this way, we can affinity capture DNA fragments containing the modified 5-hmC and develop sequencing methods to determine the precise locations of 5-hmC. Building on our early successes we propose to develop single base-resolution detection and sequencing methods to reveal the distribution of 5-hmC in mammalian genomes. We propose two different approaches, both utilizing the selective chemical labeling strategy we have developed. In one approach, we will label 5-hmC with bulky groups to hinder ligation and linear PCR reactions, thus achieving single base-resolution detection of 5-hmC. The linear PCR approachcan be adapted into the next generation Solexa sequencing to perform high throughput determination of 5-hmC in mammalian genomes. In an alternative approach, we wil develop an exonuclease digestion blockage method that detects modified 5-hmC at 3' end of undigested DNA fragments using the next generation Solexa sequencing; we have already shown that the chemically modified 5-hmC blocks exonuclease III digestion at 3' end of the modified 5-hmC. The new technologies proposed in this SBIR application not onlyhave great values as commercial research reagents, but also promise to efficiently discover and detect 5-hmC as biomarkers in various human diseases. PUBLIC HEALTH RELEVANCE: 5-Hydroxymethylcytosine (5-hmC) is a newly discovered base modificationsurprisingly abundant in the genomic DNAs of certain mammalian tissues and cells. The proposed work will develop efficient chemical labeling methods to perform single base-resolution detection and sequencing of 5-hmC in genomic DNAs. The success of the proposed work will enable the researchers to reveal the fundamental role(s) of 5-hmC in biology and develop potential disease markers.

Principal Investigator:

Shuang Chang
301-318-3650
rnaie2005@gmail.com

Business Contact:

Wei Xhang
301-318-3650
wei_zhang@cinlanian.com
Small Business Information at Submission:

CINLANIAN BIOTECHNOLOGY, INC.
4095 CLAIRMONT ROAD ATLANTA, GA 30341-

EIN/Tax ID: 127303582
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No